Spectral MD Holdings Ltd
LSE:SMD
Spectral MD Holdings Ltd
LSE:SMD
Price:
58
GBX
10.48%
Market Cap:
£79.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Spectral MD Holdings Ltd
LSE:SMD
|
US |
|
Fulin Plastic Industry (Cayman) Holding Co Ltd
TWSE:1341
|
VN |
|
Wendt (India) Limited
NSE:WENDT
|
IN |
|
G
|
Graft Polymer UK PLC
LSE:GPL
|
UK |
|
S.A.M Trade (Asia) Pte Ltd
OTC:SMFX
|
US |
|
freenet AG
XETRA:FNTN
|
DE |
|
Societe Fonciere Lyonnaise SA
PAR:FLY
|
FR |
|
WeCommerce Holdings Ltd
XTSX:WE
|
CA |
|
R
|
Reliance Infrastructure Ltd
BSE:500390
|
IN |
|
Steel Authority of India Ltd
NSE:SAIL
|
IN |
|
Harapan Duta Pertiwi Tbk PT
IDX:HOPE
|
ID |
|
W
|
Woolworths Holdings Ltd
JSE:WHL
|
ZA |
|
A
|
Atlas Cycles (Haryana) Ltd
NSE:ATLASCYCLE
|
IN |
|
E
|
Elron Ventures Ltd
TASE:ELRN
|
IL |
|
Silicon Motion Technology Corp
NASDAQ:SIMO
|
TW |
|
Azelis Group
LSE:0AA6
|
BE |
|
Starts Proceed Investment Corp
TSE:8979
|
JP |
|
B
|
Bal Pharma Ltd
NSE:BALPHARMA
|
IN |
|
Ulisse Biomed Spa
MIL:UBM
|
IT |
Relative Value
There is not enough data to reliably calculate the relative value of SMD.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
SMD
Relative Value
Base Case
Not Available
Multiples Across Competitors
SMD Competitors Multiples
Spectral MD Holdings Ltd Competitors
Spectral MD Holdings Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Spectral MD Holdings Ltd
LSE:SMD
|
78.5m GBP | 4.2 | -36.4 | -44.3 | -34.8 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
183.1B USD | 4.1 | 28.1 | 16.1 | 22.1 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
169.7B USD | 16.9 | 59.4 | 45.1 | 55.4 | |
| US |
|
Stryker Corp
NYSE:SYK
|
128.4B USD | 5.1 | 39.6 | 20.2 | 24.4 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
110.6B USD | 3.1 | 24 | 13.3 | 19.3 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
103B USD | 5.1 | 35.6 | 20.9 | 28.1 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.9B USD | 7.9 | 44.7 | 24.6 | 26.9 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
41.2B EUR | 1.7 | 19 | 10.7 | 15.1 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
46B USD | 10.7 | 43.4 | 30.8 | 34.1 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
43.9B USD | 2 | 25 | 9.9 | 16.7 | |
| US |
|
Resmed Inc
NYSE:RMD
|
32.9B USD | 6.1 | 22.2 | 15.6 | 17.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
